1. CD4 regulatory T cells in human cancer pathogenesis

   • Keith L. Knutson
   • Mary L. Disis
   • Lupe G. Salazar

   Review 04 July 2006 Pages: 271 - 285

2. The cytotoxic T cell response to peptide analogs of the HLA-A*0201-restricted MUC1 signal sequence epitope, M1.2

   • Malcolm S. Mitchell
   • Teri A. Lund
   • June Kan-Mitchell

   Original Article 28 July 2006 Pages: 287 - 301

   

3. Efficient inhibition of EGFR signalling and of tumour growth by antagonistic anti-EGFR Nanobodies

   • Rob C. Roovers
   • Toon Laeremans
   • Paul M. P. van Bergen en Henegouwen

   Original Article 30 May 2006 Pages: 303 - 317

   

4. An altered peptide ligand for naïve cytotoxic T lymphocyte epitope of TRP-2_(180–188) enhanced immunogenicity

   • Yan Tang
   • Zhihua Lin
   • Yuzhang Wu

   Original Article 12 August 2006 Pages: 319 - 329

   

5. Successful tumor eradication was achieved by collaboration of augmented cytotoxic activity and anti-angiogenic effects following therapeutic vaccines containing helper-activating analog-loaded dendritic cells and tumor antigen DNA

   • Koji Teramoto
   • Keiichi Kontani
   • Kazumasa Ogasawara

   Original Article 05 August 2006 Pages: 331 - 342

   

6. Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis

   • Kai-Da Wu
   • Li Zhou
   • Malcolm A. S. Moore

   Original Article 11 July 2006 Pages: 343 - 357

   

7. Colon carcinoma cells induce CXCL11-dependent migration of CXCR3-expressing cytotoxic T lymphocytes in organotypic culture

   • Klara Berencsi
   • Neal J. Meropol
   • Dorothee Herlyn

   Original Article 17 June 2006 Pages: 359 - 370

   

8. Association of cytokine gene polymorphisms with malignant melanoma in Caucasian population

   • Penka N. Nikolova
   • Graham P. Pawelec
   • Elissaveta J. Naumova

   Original Article 12 July 2006 Pages: 371 - 379

   

9. Successful induction of clinically competent dendritic cells from granulocyte colony-stimulating factor-mobilized monocytes for cancer vaccine therapy

   • Yuji Ueda
   • Tsuyoshi Itoh
   • Hisakazu Yamagishi

   Original Article 08 July 2006 Pages: 381 - 389

   

10. Addition of GM-CSF to a peptide/KLH vaccine results in increased frequencies of CXCR3-expressing KLH-specific T cells

    • Il-Kang Na
    • Ulrich Keilholz
    • Carmen Scheibenbogen

    Original Article 19 July 2006 Pages: 391 - 396

    

11. CIMT meets Strategies for Immune Therapy: Mainz, Germany, 04–05 May 2006

    • C. Gouttefangeas
    • C. M. Britten
    • G. Pawelec

    Meeting Report 11 August 2006 Pages: 397 - 402

12. Cancer immunotherapy 2006 meets strategies for immune therapy

    Abstracts 01 September 2006 Pages: 403 - 427